UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients

Critical care (London, England), 2014-12, Vol.18 (6), p.714-714, Article 714

2014

Volltextzugriff (PDF)

Anaphylaxis: Underdiagnosed, Underreported, and Undertreated

The American journal of medicine, 2014, Vol.127 (1), p.S1-S5

2014

Volltextzugriff (PDF)

Joint effects of advancing age and number of potentially inappropriate medication classes on risk of falls in Medicare enrollees

BMC geriatrics, 2019-07, Vol.19 (1), p.194-194, Article 194

2019

Volltextzugriff (PDF)

Anaphylaxis: A Payor's Perspective on Epinephrine Autoinjectors

The American journal of medicine, 2014, Vol.127 (1), p.S45-S50

2014

Volltextzugriff (PDF)

Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race

Journal of attention disorders, 2020-01, Vol.24 (1), p.10-19

2020

Volltextzugriff (PDF)

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-02, Vol.41 (2), p.213-228

2018

Volltextzugriff (PDF)

Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration

BMC research notes, 2018-07, Vol.11 (1), p.523-523, Article 523

2018

Volltextzugriff (PDF)

Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care

American journal of health-system pharmacy, 2009-11, Vol.66 (22), p.2027-2031

2009

Volltextzugriff (PDF)

Combined Gabapentinoid and Opioid Use

Annals of internal medicine, 2019-06, Vol.170 (12), p.908

2019

Volltextzugriff (PDF)

Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: An assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry

Clinical therapeutics, 2009-01, Vol.31, p.1478-1487

2009

Volltextzugriff (PDF)

Economic Implications of Sleep Disorders

PharmacoEconomics, 2010-11, Vol.28 (11), p.1015-1023

2010

Volltextzugriff (PDF)

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Clinical drug investigation, 2017-08, Vol.37 (8), p.763-773

2017

Volltextzugriff (PDF)

Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?

Expert opinion on drug safety, 2018-05, Vol.17 (5), p.519-523

2018

Volltextzugriff (PDF)

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-06, Vol.41 (6), p.643-644

2018

Volltextzugriff (PDF)

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

PharmacoEconomics, 2014, Vol.32 (1), p.5-13

2014

Volltextzugriff (PDF)

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995

Clinical pediatrics, 1999-04, Vol.38 (4), p.209-217

1999

Volltextzugriff (PDF)

Quantifying Gabapentin Misuse With Opioids

Primary care companion for CNS disorders, 2019-03, Vol.21 (2)

2019

Volltextzugriff (PDF)

Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?

General hospital psychiatry, 2008, Vol.30 (1), p.73-76

2008

Volltextzugriff (PDF)

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure

The journal of clinical psychiatry, 2012, Vol.73 Suppl 1 (suppl 1), p.31-36

2012

Volltextzugriff (PDF)

MAOIs: issues in treatment adherence and rates of treatment failure

The journal of clinical psychiatry, 2013, Vol.74 (1), p.e02

2013

Volltextzugriff (PDF)

Introduction: a fresh look at monoamine oxidase inhibitors for depression

The journal of clinical psychiatry, 2012, Vol.73 Suppl 1 (suppl 1), p.3-4

2012

Volltextzugriff (PDF)

Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat

Applied health economics and health policy, 2017-04, Vol.15 (2), p.203-214

2017

Volltextzugriff (PDF)

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

International clinical psychopharmacology, 2008-03, Vol.23 (2), p.106-109

2008

Volltextzugriff (PDF)

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Clinical drug investigation, 2012-02, Vol.32 (2), p.139-144

2012

Volltextzugriff (PDF)

Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome

Headache, 2012-02, Vol.52 (2), p.198-203

2012

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

Humans
(79)
Life Sciences & Biomedicine
(58)
Science & Technology
(58)
Female
(46)
Male
(41)
Adult
(35)
Middle Aged
(34)
Aged
(28)
Pharmacology & Pharmacy
(28)
United States
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Adolescent
(18)
Pharmacology. Drug Treatments
(17)
Retrospective Studies
(14)
United States - Epidemiology
(14)
Drug Therapy
(13)
Medicine
(12)
Medicine & Public Health
(12)
Public, Environmental & Occupational Health
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients

Anaphylaxis: Underdiagnosed, Underreported, and Undertreated

Joint effects of advancing age and number of potentially inappropriate medication classes on risk of falls in Medicare enrollees

Anaphylaxis: A Payor's Perspective on Epinephrine Autoinjectors

Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration

Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care

Combined Gabapentinoid and Opioid Use

Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: An assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry

Economic Implications of Sleep Disorders

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995

Quantifying Gabapentin Misuse With Opioids

Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure

MAOIs: issues in treatment adherence and rates of treatment failure

Introduction: a fresh look at monoamine oxidase inhibitors for depression

Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome

Aktive Filter

Suchergebnisse filtern